Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

AbbVie Says EMA Validates MAA For Epcoritamab To Treat Relapsed/refractory Diffuse Large B-cell

Por: RTTNews Health October 28, 2022

thumbnail

AbbVie () announced Friday that the European Medicines Agency (EMA) has validated a Marketing Authorization Application (MAA) for epcoritamab (DuoBody-CD3xCD20), an investigational subcutaneous bispecific antibody, for the treatment of adult patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy.Additionally, Genmab has submitted a Biologics License Application (BLA) to the U.S.... + full article



Similar News

Is Gold Ready For Lift-Off?

Forbes USA Business November 27, 2022

thumbnailGold with Dart Arrows. 3d rendergetty The 40-year high in most measures of inflation has not helped gold prices in 2022. The gold futures closed in 2021 at $1828 and just before the Thanksgiving holiday were trading at $1745 which was a decline of 4.5% for the year. The recent... + más

How much is gold worth? | CBS News

Where can you buy gold? | CBS News


How an experimental treatment beat a little girl's cancer

CBS News USA Politics October 30, 2022

thumbnailEmily Whitehead has a secret weapon: My T-cells, part of my immune system, were trained to fight and kill my cancer.She was only six when she became the first child ever to receive genetically-modified T cells. The experimental treatment cured her leukemia, and the success of... + más

What is metastatic breast cancer? | WPLG Local 10

Cancer vaccine may be ready by 2030, say founders of COVID vaccine-makers BioNTech | ABC7


Ligand' License Partner Janssen Received FDA Approval For Tecvayli For Refractory Multiple Myeloma

RTTNews USA Health October 26, 2022

thumbnailLigand Pharmaceuticals Inc. () announced Wednesday that its licensing partner Janssen Biotech, Inc. has received approval from the FDA for Tecvayli or teclistamab for the treatment of relapsed or refractory multiple myeloma. Teclistamab is a T-cell redirecting, bispecific... + más

Don’t Pay for Cord-Blood Banking | The Atlantic

ALS drug wins FDA approval despite questionable data | ABC News


Don’t Pay for Cord-Blood Banking

The Atlantic USA Health October 17, 2022

thumbnailUmbilical blood can be a valuable treatment for rare diseases. But that doesn’t mean you need to pay thousands of dollars to bank your baby’s.The AtlanticOctober 17, 2022, 1:12 PM ETUpdated at 3:30 p.m. ET on October 17, 2022In the fall of 1988, , a 5-year-old boy with a... + más

Woman saved by 'cord blood' transplant: How it’s helping more bone marrow transplant recipients | ABC News

These 3 Canadian banks offer the most in-demand emerging mobile features | Business Insider


Prime Video’s Aparna Purohit Reveals How Madhuri Dixit Got Onboard For ‘Maja Ma’

Forbes USA Business October 09, 2022

thumbnailBollywood actress Madhuri Dixit poses for pictures during the promotion of the Amazon Prime Video ... [+] first original Indian Hindi-language film 'Maja Maa' in Mumbai Mumbai on September 22, 2022. (Photo by SUJIT JAISWAL / AFP) (Photo by SUJIT JAISWAL/AFP via Getty... + más

Madhuri Vijay on Cruelty as Righteousness | The Atlantic

This Baltimore Restaurateur Promotes Rare Ingredients From The Amazon In Her Bar Program | Forbes


From Lymphoma To Lupus And Beyond: The Remarkable Research Of CAR T Therapy

Forbes USA Tech October 03, 2022

thumbnailMalignant cell destroyed by engineered T cells with wrecking ball forcegetty This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This first installment will lay the foundation for understanding how CAR T works. Future... + más

Alzheimer's Q&A: Bright light therapy has multiple benefits | The Advocate

Snoop Dogg And Shante Broadus Debut The Broadus Collection, A Luxury Scarf Line To Support Daughter’s Fight With Lupus | Forbes


Study: Too few kids with sickle cell get stroke screen, care

Associated Press USA Science September 21, 2022

thumbnailFILE - This 2009 colorized microscope image made available by the Sickle Cell Foundation of Georgia via the Centers for Disease Control and Prevention shows a sickle cell, left, and normal red blood cells of a patient with sickle cell anemia. A study of U.S. children with sickle... + más

Study: Too few kids with sickle cell get stroke screen, care | ABC News

Playing with your emotions? A Boston video game startup aims to help kids regulate their behavior. | The Boston Globe



About iurex | Privacy Policy | Disclaimer |